World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
99
Citations
43282
World Ranking
8485
National Ranking
4381

Charles L. Bennett publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Charles L. Bennett sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 709 publications — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Charles L. Bennett D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Charles L. Bennett sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 99 D-Index — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Charles L. Bennett is affiliated with the University of South Carolina in the United States and specializes in the field of Medicine. Their research output spans several subfields, including Oncology, Economics and Econometrics, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, and Immunology.

The main topics of Charles L. Bennett's work encompass a diverse range of medical and scientific issues. These topics include:

  • Prostate Cancer Treatment and Research
  • Pharmaceutical Economics and Policy
  • Health Systems, Economic Evaluations, Quality of Life
  • Pharmacovigilance and Adverse Drug Reactions
  • Radiopharmaceutical Chemistry and Applications
  • Biosimilars and Bioanalytical Methods
  • Global Cancer Incidence and Screening

Several frequent publication venues illustrate the domains in which Bennett has contributed extensively. These include:

  • Cancer treatment and research
  • UNC Libraries
  • Journal of Clinical Oncology
  • Expert Opinion on Drug Safety
  • Blood

Collaboration is a prominent feature of Bennett's research. Frequent co-authors include:

  • Kenneth R. Carson
  • Kevin Knopf
  • Martin W. Schoen
  • William J.M. Hrushesky
  • Shamia Hoque

Notable papers authored by or involving Charles L. Bennett reflect a range of contemporary medical topics. Some recent publications are:

  • Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update, 2021, Journal of Clinical Oncology
  • Repurposing anti-inflammasome NRTIs for improving insulin sensitivity and reducing type 2 diabetes development, 2020, Nature Communications
  • Cytoplasmic synthesis of endogenous Alu complementary DNA via reverse transcription and implications in age-related macular degeneration, 2021, Proceedings of the National Academy of Sciences
  • Progressive multifocal leukoencephalopathy in patients treated with rituximab: a 20-year review from the Southern Network on Adverse Reactions, 2021, The Lancet Haematology
  • Survival of veterans treated with enzalutamide and abiraterone for metastatic castrate resistant prostate cancer based on comorbid diseases, 2022, Prostate Cancer and Prostatic Diseases

Best Publications

  • 2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline

    Thomas J. Smith;James Khatcheressian;Gary H. Lyman;Howard Ozer

  • 2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines*

    Thomas J. Smith;Howard Ozer;Langdon L. Miller;Charles A. Schiffer

  • Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology.

    J. Douglas Rizzo;Alan E. Lichtin;Steven H. Woolf;Jerome Seidenfeld

  • Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project.

    Kenneth R. Carson;Andrew M. Evens;Elizabeth A. Richey;Thomas M. Habermann

  • Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia.

    Charles L. Bennett;Samuel M. Silver;Benjamin Djulbegovic;Athena T. Samaras

  • Assessing the impact of continuous quality improvement on clinical practice: what it will take to accelerate progress.

    Stephen M. Shortell;Charles L. Bennett;Gayle R. Byck

  • Hypersensitivity Cases Associated With Drug-Eluting Coronary Stents: A Review of Available Cases From the Research on Adverse Drug Events and Reports (RADAR) Project

    Jonathan R. Nebeker;Jonathan R. Nebeker;Renu Virmani;Charles L. Bennett;Charles L. Bennett;Jennifer M. Hoffman;Jennifer M. Hoffman

  • Thrombotic thrombocytopenic purpura associated with clopidogrel.

    Charles L. Bennett;Jean M. Connors;John M. Carwile;Joel L. Moake

  • Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years.

    Karl Y Bilimoria;David Jason Bentrem;Jeffrey D Wayne;Clifford Y. Ko;Clifford Y. Ko

  • Recombinant Human Erythropoietins and Cancer Patients: Updated Meta-Analysis of 57 Studies Including 9353 Patients

    Julia Bohlius;Jayne Wilson;Jerome Seidenfeld;Margaret Piper

  • Platelet Transfusion for Patients With Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology*

    Charles A. Schiffer;Kenneth C. Anderson;Charles L. Bennett;Steven Bernstein

  • Initial Hormonal Management of Androgen-Sensitive Metastatic, Recurrent, or Progressive Prostate Cancer: 2007 Update of an American Society of Clinical Oncology Practice Guideline

    D. Andrew Loblaw;Katherine S. Virgo;Robert Nam;Mark R. Somerfield

  • The learning curve for laparoscopic cholecystectomy

    Michael J. Moore;Charles L. Bennett

  • Single-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysis.

    Jerome Seidenfeld;David J. Samson;Vic Hasselblad;Naomi Aronson

  • Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project

    Kenneth R Carson;Daniele Focosi;Eugene O Major;Mario Petrini

  • The association of health literacy with cervical cancer prevention knowledge and health behaviors in a multiethnic cohort of women.

    Stacy T. Lindau;Cecilia Tomori;Tom Lyons;Lizbet Langseth

  • The uncertainty principle and industry-sponsored research

    Benjamin Djulbegovic;Mensura Lacevic;Alan Cantor;Karen K Fields

  • Low Literacy Impairs Comprehension of Prescription Drug Warning Labels

    Terry C. Davis;Michael S. Wolf;Pat F. Bass;Mark Middlebrooks

  • Outcomes of cancer treatment for technology assessment and cancer treatment guidelines

    John Fetting;Paul Anderson;Harrison Ball;John Benear

  • Thrombotic Thrombocytopenic Purpura Associated with Ticlopidine: A Review of 60 Cases

    Charles L. Bennett;Peter D. Weinberg;Karine Rozenberg-Ben-Dror;Karine Rozenberg-Ben-Dror;Paul R. Yarnold

Frequent Co-Authors

Oliver Sartor
Oliver Sartor Tulane University
Michael S. Wolf
Michael S. Wolf Northwestern University
Hau C. Kwaan
Hau C. Kwaan Northwestern University
Timothy M. Kuzel
Timothy M. Kuzel Rush University Medical Center
Robert A. Weinstein
Robert A. Weinstein Rush University Medical Center
Benjamin Djulbegovic
Benjamin Djulbegovic City Of Hope National Medical Center
Joan S. Chmiel
Joan S. Chmiel Northwestern University
Alfred W. Rademaker
Alfred W. Rademaker Northwestern University
Thomas L. Ortel
Thomas L. Ortel Duke University
Matthew Bidwell Goetz
Matthew Bidwell Goetz University of California, Los Angeles

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in medicine goes beyond becoming a physician. Many students consider related online degrees to open doors in healthcare fields that are in high demand and offer flexibility.

For those interested in the field of pharmacy but seeking cost-effective options, online pharmd programs can be a pathway to advanced clinical practice and pharmaceutical research.

Another growing area is health information management. healthcare informatics degree programs prepare graduates to analyze and manage patient data, supporting both clinical and administrative needs.

Those looking for entry into healthcare administration may consider the cheapest medical billing and coding online courses. These courses train students to handle medical records and insurance claims, making them essential to the business side of healthcare.

Nursing is another vital profession. For registered nurses ready to advance, the cheapest fnp programs offer accessible routes to becoming a Family Nurse Practitioner, opening pathways to higher responsibility and salary.

Whether your interest is clinical or administrative, these online degree options can help you start or advance your career in medicine and healthcare.

Best Scientists Citing Charles L. Bennett

Trending Scientists

Recently Published Articles